§360

15 cases·2 followed·2 overruled·11 cited—13% support

Statute Text — 26 U.S.C. §360

Statute text not available for this section.

15 Citing Cases

United Therapeutics Corporation, Petitioner 160 T.C. No. 12 · 2023

§§ 360aa–360ee and I.R.C. § 44H). “The Orphan Drug Act incentivizes pharmaceutical companies to develop ‘orphan drugs’—drugs for rare diseases that affect such a small portion of the population that there otherwise would be no financial incentive to research and develop treatments.” Catalyst Pharms., Inc. v. Becerra, 14 F.4th 1299, 1302 (11th Cir. 2

NRDC v. US FDA · Cir.

Brown & Williamson v. FDA · Cir.

Brooks v. Howmedica 236 F.3d 956 · Cir.

Natural Resources Defense Council, Inc. v. United States Food & Drug Administration 760 F.3d 151 · Cir.

Sharp v. Commissioner 75 T.C. 21 · 1980

Knollwood Memorial Gardens v. Commissioner 46 T.C. 764 · 1966

Lady v. Neal Glaser Marine, Inc. 228 F.3d 598 · Cir.

ND State University v. United States · Cir.

United States v. Vahan Kelerchian 937 F.3d 895 · Cir.

United States v. Vahan Kelerchian · Cir.

United States v. Weintraub 273 F.3d 139 · Cir.

North Dakota State University, an Agency of the State of North Dakota, Appellee v. United States of America, Appellant/ Cross-Appellee 255 F.3d 599 · Cir.

United States v. Weintraub 273 F.3d 139 · Cir.

United States v. Richard Marschall 82 F.4th 774 · Cir.